Jushi Holdings JUSHF
OTC JUSHF
$0.42 +0.01 (+2.44%)
At close: Aug 7, 2026 · 4:00 PM EDT

Jushi Holdings (JUSHF) Cash & Current Investments (2021 - 2026)

Jushi Holdings (JUSHF) posted quarterly Cash & Current Investments of $33.3 million for Q2 2026, up 43.62% year-over-year from $23.2 million in Q2 2025, and down 16.05% quarter-over-quarter from $39.7 million in Q1 2026.

Jushi Holdings (JUSHF) Cash & Current Investments (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has reported Cash & Current Investments for 6 consecutive years, with $33.3 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Cash & Current Investments rose 43.62% year-over-year to $33.3 million; the TTM figure through Jun 2026 stood at $33.3 million (up 43.62% YoY), while the FY2025 annual figure was $24.0 million, up 23.19% from the prior year.
  • Cash & Current Investments declined to $33.3 million in Q2 2026 per JUSHF's latest filing, from $39.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $43.2 million in Q2 2022 and bottomed at $18.5 million in Q1 2023.
  • Historically, Cash & Current Investments has averaged $28.1 million across 5 years, with a median of $28.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments tumbled 72.41% — and 2024, when it surged 53.81%.
  • Jushi Holdings' Cash & Current Investments stood at $26.2 million in 2022, then climbed by 11.3% to $29.2 million in 2023, then slumped by 33.04% to $19.5 million in 2024, then increased by 23.19% to $24.0 million in 2025, then soared by 38.6% to $33.3 million in 2026.
  • Business Quant data shows JUSHF's Cash & Current Investments at $33.3 million in Q2 2026, $39.7 million in Q1 2026, and $24.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 963.33 Mn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 3.66 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 1.68 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 5.80 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 2.66 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 886.50 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 389.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 530.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 164.00 Mn
10 Jushi Holdings 83.87 Mn 50.54 Mn 31.53 Mn 33.33 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 33.33 Mn
Mar 31, 2026 39.70 Mn
Dec 31, 2025 24.05 Mn
Sep 30, 2025 23.17 Mn
Jun 30, 2025 23.21 Mn
Mar 31, 2025 25.96 Mn
Dec 31, 2024 19.52 Mn
Sep 30, 2024 20.74 Mn
Jun 30, 2024 32.88 Mn
Mar 31, 2024 28.41 Mn
Dec 31, 2023 29.16 Mn
Sep 30, 2023 28.32 Mn
Jun 30, 2023 29.91 Mn
Mar 31, 2023 18.47 Mn
Dec 31, 2022 26.20 Mn
Sep 30, 2022 31.06 Mn
Jun 30, 2022 43.19 Mn
Dec 31, 2021 94.96 Mn